Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund Fonds
60,27
USD
-0,38
USD
-0,63
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 9,59% |
| UCB SA | BE0003739530 | 7,28% |
| argenx SE | NL0010832176 | 5,95% |
| Zealand Pharma AS | DK0060257814 | 4,66% |
| Teva Pharmaceutical Industries Ltd ADR | US8816242098 | 4,65% |
| Fresenius SE & Co KGaA | DE0005785604 | 3,88% |
| Chugai Pharmaceutical Co Ltd | JP3519400000 | 3,50% |
| Boston Scientific Corp | US1011371077 | 3,42% |
| Cytokinetics Inc | US23282W6057 | 3,25% |
| Ascendis Pharma AS ADR | US04351P1012 | 3,04% |
| Sonstige | 50,79% |